Skip to main content
Log in

Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index

  • Original Papers
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

The usefulness of histopathological grading in predicting the prognosis of patients with ependymomas is controversial. To clarify the discrepancy between the histological malignancy and the prognosis of these tumors, we estimated the proliferative potential of 32 intracranial and intraspinal ependymomas and correlated the findings with the clinical behavior. Each patient received an intraoperative infusion of bromodeoxyuridine (BUdR, 200 mg/m2 i.v.) before tumor removal; the BUdR labeling index (LI), or percentage of BUdR-labeled cells, was determined immunohistochemically in excised specimens. The mean BUdR LI (±SD) of intracranial malignant ependymomas was 4.1±2.8%. Nonmalignant intracranial and intraspinal ependymomas and subependymomas had mean LIs of 1.5±0.9%, 1.1±0.3%, and <1%, respectively. Overall, 44% of the tumors recurred. There were no statistically significant differences in the recurrence rates of intracranial and intraspinal ependymomas, including subependymomas (43% and 44%, respectively), or of intracranial ependymomas with LIs greater than 1.0% and less than 1.0% (67% and 44%, respectively). However, the early recurrence rate (within 24 months after treatment) of tumors with LIs greater than 1.0% was higher than that of tumors with LIs of less than 1.0% (100% vs. 25%, P<0.05). The BUdR LI also showed a statistically significant inverse correlation with the time to recurrence. These findings indicate that BUdR LI reflects the proliferative potential of individual ependymomas and can be used to help predict the recurrence and estimate the prognosis of these tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Afra D, Muller W, Slowik F, Wilcke O, Budka H, Turoczy L (1983) Supratentorial lobar ependymomas: reports on the grading and survival periods in 80 cases, including 46 recurrences. Acta Neurochir (Wien) 69:243–251

    Google Scholar 

  2. Barone BM, Elvidge AR (1970) Ependymomas: a clinical survey. J Neurosurg 33:428–438

    Google Scholar 

  3. Cooper PR, Epstein F (1985) Radical resection of intramedullary spinal cord tumors in adults. Recent experience in 29 patients. J Neurosurg 63:492–499

    Google Scholar 

  4. Di Marco A, Griso C, Pradella R, Campostrini F, Garusi GF (1988) Postoperative management of primary spinal cord ependymomas. Acta Oncol 27:371–375

    Google Scholar 

  5. Dohrmann GJ, Farwell JR, Flannery JT (1976) Ependymomas and ependymoblastomas in children. J Neurosurg 45:273–283

    Google Scholar 

  6. Enzmann DR, Norman D, Levin V, Wilson CB, Newton TH (1978) Computed tomography in the follow-up of medulloblastomas and ependymomas. Radiology 128:57–63

    Google Scholar 

  7. Fischer G, Mansuy L (1980) Total removal of intramedullary ependymomas: follow-up study of 16 cases. Surg Neurol 14:243–249

    Google Scholar 

  8. Garrett PG, Simpson WJK (1983) Ependymomas: results of radiation treatment. Int J Radiat Oncol Biol Phys 9:1121–1124

    Google Scholar 

  9. Hoshino T, Prados M, Wilson CB, Cho KG, Lee K-S, Davis RL (1989) Prognostic implications of bromodeoxyuridine labeling index of human gliomas. J Neurosurg 71:335–341

    Google Scholar 

  10. Kim YH, Fayos JV (1977) Intracranial ependymomas. Radiology 124:805–808

    Google Scholar 

  11. Kopelson G, Linggood RM, Kleinman GM, Doucette J, Wang CC (1980) Management of intramedullary spinal cord tumors. Radiology 135:473–479

    Google Scholar 

  12. Kricheff II, Becker M, Schneck SA, Taveras JM (1964) Intracranial ependymomas: factors influencing prognosis. J Neurosurg 21:7–14

    Google Scholar 

  13. Marks JE, Adler SJ (1982) A comparative study of ependymomas by site of origin. Int J Radiat Oncol Biol Phys 8:37–43

    Google Scholar 

  14. Matsumura A, Ahyai A, Hori A, Schaake T (1989) Intracerebral subependymomas. Clinical and neuropathological analysis with special reference to the possible existence of a less benign variant. Acta Neurochir (Wien) 96:15–25

    Google Scholar 

  15. Mork SJ, Loken AC (1977) Ependymoma. A follow-up study of 101 cases. Cancer 40:907–915

    Google Scholar 

  16. Nagashima T, DeArmond SJ, Murovic J, Hoshino T (1985) Immunocytochemical demonstration of S-phase cells by antibromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol (Berl) 67:155–159

    Google Scholar 

  17. Nagashima T, Hoshino T, Cho KG, Edwards MSB, Hudgins RJ, Davis RL (1988) The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling. Cancer 61:2433–2438

    Google Scholar 

  18. Nazar GB, Hoffman HJ, Becker LE, Jenkin D, Humphreys RP, Hendrick EB (1990) Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 72:408–417

    Google Scholar 

  19. Phillips TL, Sheline GE, Boldrey E (1964) Therapeutic considerations in tumors affecting the central nervous system: ependymomas. Am J Roentgenol 83:98–105

    Google Scholar 

  20. Rorke LB, Gilles FH, Davis RL, Becker LE (1985) Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 56:1869–1886

    Google Scholar 

  21. Ross GW, Rubinstein LJ (1989) Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 70:31–36

    Google Scholar 

  22. Russell DS, Rubinstein IJ (1977) Pathology of tumours of the nervous system, 4th edn. Arnold, London, pp 212–213

    Google Scholar 

  23. Salazar OM, Castro-Vita H, VanHoutte P, Rubin P, Aygun C (1983) Improved survival in cases of intracranial ependymoma after radiation therapy. Late report and recommendations. J Neurosurg 59:652–659

    Google Scholar 

  24. Shuman RM, Alvord EC, Leech RW (1975) The biology of childhood ependymomas. Arch Neurol 32:731–739

    Google Scholar 

  25. Wallner KE, Wara WM, Sheline GE, Davis RL (1986) Intracranial ependymomas: results of treatment with partial or whole brain irradiation without spinal irradiation. Int J Radiat Oncol Biol Phys 12:1937–1941

    Google Scholar 

Reference

  1. Schiffer D, Chio A, Cravioto H, Giordana MT, Migheli A, Palma L, Pollo B, Soffietti R, Tribolo A (1991) Ependymoma: internal correlations among pathological signs. The anaplastic variant. Neurosurgery 29:206–210

    Google Scholar 

  2. Schiffer D, Chio A, Giordana MT, Migheli A, Palma L, Pollo B, Soffietti R, Tribolo A (1991) Histologic prognostic factors in ependymoma. Child's Nerv Syst 7:177–182

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Asai, A., Hoshino, T., Edwards, M.S.B. et al. Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index. Child's Nerv Syst 8, 273–278 (1992). https://doi.org/10.1007/BF00300795

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00300795

Key words

Navigation